I have dedicated my career to study of the intersection of materials science and medicine with the goal of creating products to improve patients’ lives. At Arsenal Medical, I have led the development of our in situ forming foam platform. This exciting technology platform has commercial application in treating severely injured patients with abdominal hemorrhage through our ResQFoam product. I have managed ResQFoam from concept through development, securing $25M from the DOD (through DARPA and ARO). I was also the PI and inventor of an Arsenal technology that has enabled the scale up of electrospinning fibers, supported by $2.3M from NIST.
At 480 Biomedical, I was on the team that developed a novel bioresorbable scaffold technology to treat peripheral arterial disease. Through this novel composite design, we were able to achieve properties similar to metal stents, with a stent that is fully absorbable. I drove initial materials selection and oversaw preliminary drug delivery formulations. I also spearheaded the submission of a Fast-Track SBIR, resulting in a $1.7M award and initiating the development of our stent for pediatric pulmonary artery stenosis. Additionally, I oversaw our application for funding from Broadview Ventures, resulting in an additional $1.2M for the pediatric stent program.
My key areas of expertise:
--Grant Writing: Directed ideation and led the submission of government proposals resulting in over $27M of funding from DARPA and NIH
--Product Development: Led development and execution of our ResQFoam product including regulatory strategy and submissions, design control process and contract manufacturing, project timeline and budget, and establishment of a world-class advisory board
--Technical Management: Managed R&D group of up to 10 engineers & technicians
--Intellectual Property: Inventor on more than 25 pending or issued patents
--Publications: Authored 18 peer-reviewed scientific publications and 30+ presentations